Cencora Pre-Tax Profit Margin 2012-2025 | COR
Current and historical pre-tax profit margin for Cencora (COR) from 2012 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Cencora pre-tax profit margin for the three months ending December 31, 2025 was .
| Cencora Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-12-31 | $325.78B | $2.35B | 0.72% |
| 2025-09-30 | $321.33B | $2.26B | 0.70% |
| 2025-06-30 | $316.66B | $2.57B | 0.81% |
| 2025-03-31 | $310.23B | $2.30B | 0.74% |
| 2024-12-31 | $303.19B | $1.84B | 0.61% |
| 2024-09-30 | $293.96B | $2.00B | 0.68% |
| 2024-06-30 | $283.83B | $2.32B | 0.82% |
| 2024-03-31 | $276.54B | $2.31B | 0.83% |
| 2023-12-31 | $271.58B | $2.35B | 0.87% |
| 2023-09-30 | $262.17B | $2.16B | 0.82% |
| 2023-06-30 | $254.43B | $2.10B | 0.82% |
| 2023-03-31 | $247.54B | $1.96B | 0.79% |
| 2022-12-31 | $241.81B | $2.18B | 0.90% |
| 2022-09-30 | $238.59B | $2.18B | 0.91% |
| 2022-06-30 | $236.33B | $2.35B | 1.00% |
| 2022-03-31 | $229.67B | $2.45B | 1.07% |
| 2021-12-31 | $221.10B | $2.29B | 1.04% |
| 2021-09-30 | $213.99B | $2.22B | 1.04% |
| 2021-06-30 | $204.32B | $-4.47B | -2.19% |
| 2021-03-31 | $196.28B | $-4.70B | -2.40% |
| 2020-12-31 | $194.55B | $-5.00B | -2.57% |
| 2020-09-30 | $189.90B | $-5.29B | -2.79% |
| 2020-06-30 | $186.29B | $1.00B | 0.53% |
| 2020-03-31 | $186.16B | $1.02B | 0.55% |
| 2019-12-31 | $182.06B | $0.77B | 0.42% |
| 2019-09-30 | $179.59B | $0.97B | 0.54% |
| 2019-06-30 | $177.25B | $0.94B | 0.53% |
| 2019-03-31 | $175.15B | $0.91B | 0.52% |
| 2018-12-31 | $172.87B | $1.25B | 0.72% |
| 2018-09-30 | $167.94B | $1.18B | 0.70% |
| 2018-06-30 | $163.76B | $0.89B | 0.55% |
| 2018-03-31 | $159.33B | $0.68B | 0.43% |
| 2017-12-31 | $155.44B | $0.91B | 0.59% |
| 2017-09-30 | $153.14B | $0.92B | 0.60% |
| 2017-06-30 | $151.58B | $1.28B | 0.85% |
| 2017-03-31 | $149.76B | $1.64B | 1.10% |
| 2016-12-31 | $148.31B | $1.97B | 1.33% |
| 2016-09-30 | $146.85B | $1.39B | 0.95% |
| 2016-06-30 | $144.76B | $1.67B | 1.15% |
| 2016-03-31 | $142.11B | $1.48B | 1.04% |
| 2015-12-31 | $139.08B | $0.16B | 0.12% |
| 2015-09-30 | $135.96B | $0.27B | 0.20% |
| 2015-06-30 | $132.08B | $-0.02B | -0.01% |
| 2015-03-31 | $128.20B | $-0.26B | -0.21% |
| 2014-12-31 | $123.98B | $0.42B | 0.34% |
| 2014-09-30 | $119.57B | $0.67B | 0.56% |
| 2014-06-30 | $112.45B | $0.58B | 0.52% |
| 2014-03-31 | $104.01B | $0.64B | 0.61% |
| 2013-12-31 | $96.08B | $0.69B | 0.71% |
| 2013-09-30 | $87.96B | $0.83B | 0.94% |
| 2013-06-30 | $82.23B | $1.03B | 1.25% |
| 2013-03-31 | $79.65B | $1.22B | 1.53% |
| 2012-12-31 | $78.83B | $1.24B | 1.57% |
| 2012-09-30 | $78.08B | $1.22B | 1.56% |
| 2012-06-30 | $78.23B | $1.13B | 1.45% |
| 2012-03-31 | $79.07B | $1.13B | 1.42% |
| 2011-12-31 | $79.12B | $1.12B | 1.41% |
| 2011-09-30 | $78.70B | $1.12B | 1.42% |
| 2011-06-30 | $79.35B | $1.12B | 1.41% |
| 2011-03-31 | $78.79B | $1.08B | 1.38% |
| 2010-12-31 | $78.33B | $1.03B | 1.31% |
| 2010-09-30 | $77.78B | $1.02B | 1.31% |
| 2010-06-30 | $76.96B | $1.01B | 1.31% |
| 2010-03-31 | $75.75B | $0.94B | 1.25% |
| 2009-12-31 | $73.76B | $0.89B | 1.20% |
| 2009-09-30 | $71.76B | $0.82B | 1.15% |
| 2009-06-30 | $70.20B | $0.80B | 1.14% |
| 2009-03-31 | $69.81B | $0.79B | 1.12% |
| 2008-12-31 | $70.25B | $0.77B | 1.09% |
| 2008-09-30 | $70.19B | $0.76B | 1.08% |
| 2008-06-30 | $69.12B | $0.72B | 1.04% |
| 2008-03-31 | $67.47B | $0.73B | 1.09% |
| 2007-12-31 | $66.23B | $0.73B | 1.10% |
| 2007-09-30 | $65.67B | $0.75B | 1.15% |
| 2007-06-30 | $64.83B | $0.75B | 1.15% |
| 2007-03-31 | $64.18B | $0.74B | 1.15% |
| 2006-12-31 | $62.88B | $0.73B | 1.15% |
| 2006-09-30 | $60.81B | $0.68B | 1.12% |
| 2006-06-30 | $59.48B | $0.58B | 0.97% |
| 2006-03-31 | $57.62B | $0.55B | 0.95% |
| 2005-12-31 | $55.59B | $0.52B | 0.93% |
| 2005-09-30 | $54.58B | $0.47B | 0.86% |
| 2005-06-30 | $54.03B | $0.59B | 1.09% |
| 2005-03-31 | $53.25B | $0.64B | 1.20% |
| 2004-12-31 | $53.42B | $0.71B | 1.32% |
| 2004-09-30 | $53.12B | $0.77B | 1.45% |
| 2004-06-30 | $52.32B | $0.81B | 1.56% |
| 2004-03-31 | $51.68B | $0.79B | 1.53% |
| 2003-12-31 | $50.49B | $0.75B | 1.49% |
| 2003-09-30 | $49.59B | $0.73B | 1.47% |
| 2003-06-30 | $48.62B | $0.69B | 1.41% |
| 2003-03-31 | $47.82B | $0.65B | 1.36% |
| 2002-12-31 | $46.60B | $0.61B | 1.31% |
| 2002-09-30 | $45.24B | $0.57B | 1.26% |
| 2002-06-30 | $39.52B | $0.47B | 1.20% |
| 2002-03-31 | $31.42B | $0.38B | 1.19% |
| 2001-12-31 | $23.95B | $0.27B | 1.14% |
| 2001-09-30 | $16.19B | $0.20B | 1.25% |
| 2001-06-30 | $13.34B | $0.19B | 1.42% |
| 2001-03-31 | $12.75B | $0.18B | 1.40% |
| 2000-12-31 | $12.11B | $0.17B | 1.38% |
| 2000-09-30 | $11.65B | $0.16B | 1.37% |
| 2000-06-30 | $11.19B | $0.14B | 1.25% |
| 2000-03-31 | $10.52B | $0.13B | 1.25% |
| 1999-12-31 | $9.86B | $0.13B | 1.27% |
| 1999-09-30 | $9.19B | $0.12B | 1.30% |
| 1999-06-30 | $8.86B | $0.10B | 1.12% |
| 1999-03-31 | $8.69B | $0.09B | 1.08% |
| 1998-12-31 | $8.71B | $0.09B | 1.01% |
| 1998-09-30 | $8.79B | $0.08B | 0.94% |
| 1998-06-30 | $8.76B | $0.10B | 1.19% |
| 1998-03-31 | $8.73B | $0.09B | 1.00% |
| 1997-12-31 | $8.32B | $0.08B | 0.99% |
| 1997-09-30 | $7.82B | $0.08B | 1.00% |
| 1997-06-30 | $7.08B | $0.06B | 0.90% |
| 1997-03-31 | $6.44B | $0.07B | 1.12% |
| 1996-12-31 | $6.02B | $0.07B | 1.11% |
| 1996-09-30 | $5.55B | $0.06B | 1.12% |
| 1996-06-30 | $5.27B | $0.07B | 1.27% |
| 1996-03-31 | $5.04B | $0.06B | 1.23% |
| 1995-12-31 | $3.68B | $0.06B | 1.52% |
| 1995-09-30 | $3.55B | $0.05B | 1.30% |
| 1995-06-30 | $3.43B | $1.11B | 32.44% |
| 1995-03-31 | $3.32B | $2.18B | 65.60% |
| 1994-12-31 | $4.39B | $3.23B | 73.73% |
| 1994-09-30 | $4.28B | $4.28B | 100.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $62.409B | $321.333B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $134.187B | 24.31 |
| HCA Healthcare (HCA) | United States | $110.772B | 17.53 |
| CVS Health (CVS) | United States | $101.670B | 11.75 |
| Elevance Health (ELV) | United States | $68.432B | 10.33 |
| Natera (NTRA) | United States | $27.358B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.501B | 15.87 |
| DiDi Global (DIDIY) | China | $18.026B | 15.96 |
| Viatris (VTRS) | United States | $15.685B | 5.71 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.535B | 0.00 |
| Medpace Holdings (MEDP) | United States | $14.094B | 32.26 |
| BioMerieux (BMXMF) | France | $12.476B | 0.00 |
| Solventum (SOLV) | United States | $11.408B | 10.78 |
| Revvity (RVTY) | United States | $10.039B | 17.71 |
| BrightSpring Health Services (BTSG) | United States | $8.774B | 43.59 |
| Charles River Laboratories (CRL) | United States | $8.667B | 17.09 |
| ICON (ICLR) | Ireland | $8.626B | 8.56 |
| CochLear (CHEOY) | Australia | $8.030B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.905B | 0.00 |
| HealthEquity (HQY) | United States | $6.586B | 23.20 |
| Bausch + Lomb (BLCO) | Canada | $5.877B | 32.98 |
| GETINGE (GNGBY) | Sweden | $5.626B | 17.96 |
| Avantor (AVTR) | United States | $5.388B | 8.68 |
| PACS (PACS) | United States | $5.304B | 27.44 |
| Caris Life Sciences,�Inc (CAI) | United States | $5.101B | 0.00 |
| Sotera Health (SHC) | United States | $4.380B | 19.95 |
| Alignment Healthcare (ALHC) | United States | $4.188B | 0.00 |
| Concentras Parent (CON) | United States | $2.818B | 16.12 |
| Organon (OGN) | United States | $2.299B | 2.57 |
| Amplifon S.p.A (AMFPF) | Italy | $2.275B | 13.27 |
| Pediatrix Medical (MD) | United States | $1.782B | 11.11 |
| Establishment Labs Holdings (ESTA) | United States | $1.765B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.746B | 42.28 |
| Surgery Partners (SGRY) | United States | $1.671B | 41.65 |
| Sonida Senior Living (SNDA) | United States | $1.544B | 0.00 |
| Ardent Health (ARDT) | United States | $1.345B | 5.70 |
| Progyny (PGNY) | United States | $1.277B | 25.08 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.240B | 0.00 |
| InnovAge Holding (INNV) | United States | $1.113B | 164.00 |
| Teladoc Health (TDOC) | United States | $0.920B | 0.00 |
| CareDx (CDNA) | United States | $0.822B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.750B | 12.17 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Nutex Health (NUTX) | United States | $0.704B | 11.25 |
| Omada Health (OMDA) | United States | $0.672B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.604B | 99.85 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.531B | 0.00 |
| Embecta (EMBC) | United States | $0.524B | 2.92 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.482B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.435B | 4.70 |
| SBC Medicals (SBC) | United States | $0.426B | 8.47 |
| Forward Industries (FWDI) | United States | $0.375B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.349B | 0.00 |
| Agilon Health (AGL) | United States | $0.316B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.309B | 0.00 |
| Oncology Institute (TOI) | United States | $0.304B | 0.00 |
| So-Young (SY) | China | $0.262B | 0.00 |
| LifeMD (LFMD) | United States | $0.166B | 0.00 |
| Biodesix (BDSX) | United States | $0.133B | 0.00 |
| Beauty Health (SKIN) | United States | $0.115B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.091B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.080B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.077B | 0.00 |
| DocGo (DCGO) | United States | $0.051B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Pomdoctor - (POM) | China | $0.031B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.026B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.015B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.005B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |